Pneumonia, Bacterial - 26 Studies Found Status Study Completed Study Name: Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Condition: Pneumonia, Bacterial Date: 2007-10-01 Interventions: Drug: daptomycin Completed Study Name: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia Condition: Pneumonia, Bacterial Date: 2005-05-24 Interventions: Drug: Ceftriaxone 1000mg iv da Recruiting Study Name: A Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial Pneumonia Condition: Pneumonia, Bacterial Date: 2015-05-28 Interventions: Drug: ME1100 inhalation solution Completed Study Name: Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae Condition: Pneumonia, Bacterial Date: 2007-10-04 Interventions: Drug: daptomycin Completed Study Name: Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia Condition: Pneumonia, Bacterial Date: 2013-10-22 Interventions: Drug: Amikacin fosfomycin inhalation solution Completed Study Name: Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia Condition: Community-Acquired Bacterial Pneumonia Date: 2010-07-22 Interventions: Drug: Levofloxacin Completed Study Name: Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia Condition: Pneumonia, Bacterial Community-acquired Date: 2012-01-30 Interventions: Drug: Ceftaroline 600 mg Q12h Completed Study Name: Five Versus Seven Day Antibiotic Course for the Treatment of Pneumonia in the Intensive Care Unit Condition: Pneumonia, Bacterial Date: 2012-03-07 Interventions: Other: 5 Days of Antibiotics T Recruiting Study Name: Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014) Condition: Bacterial Pneumonia Date: 2015-07-07 Interventions: Drug: Imipenem Imipenem 500 mg Terminated Study Name: Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial Pneumonia Condition: Community-Acquired Bacterial Pneumonia (CABP) Date: 2010-09-07 Interventions: Drug: JNJ-32729463 150 mg intr Next >>>